Literature DB >> 34235936

Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.

Carl G Streed, Lauren B Beach, Billy A Caceres, Nadia L Dowshen, Kerrie L Moreau, Monica Mukherjee, Tonia Poteat, Asa Radix, Sari L Reisner, Vineeta Singh.   

Abstract

There is growing evidence that people who are transgender and gender diverse (TGD) are impacted by disparities across a variety of cardiovascular risk factors compared with their peers who are cisgender. Prior literature has characterized disparities in cardiovascular morbidity and mortality as a result of a higher prevalence of health risk behaviors. Mounting research has revealed that cardiovascular risk factors at the individual level likely do not fully account for increased risk in cardiovascular health disparities among people who are TGD. Excess cardiovascular morbidity and mortality is hypothesized to be driven in part by psychosocial stressors across the lifespan at multiple levels, including structural violence (eg, discrimination, affordable housing, access to health care). This American Heart Association scientific statement reviews the existing literature on the cardiovascular health of people who are TGD. When applicable, the effects of gender-affirming hormone use on individual cardiovascular risk factors are also reviewed. Informed by a conceptual model building on minority stress theory, this statement identifies research gaps and provides suggestions for improving cardiovascular research and clinical care for people who are TGD, including the role of resilience-promoting factors. Advancing the cardiovascular health of people who are TGD requires a multifaceted approach that integrates best practices into research, health promotion, and cardiovascular care for this understudied population.

Entities:  

Keywords:  AHA Scientific Statements; cardiovascular disease; intersectionality; minority stress theory; social determinants of health; stigma; transgender

Mesh:

Year:  2021        PMID: 34235936      PMCID: PMC8638087          DOI: 10.1161/CIR.0000000000001003

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   39.918


  67 in total

1.  Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment.

Authors:  Chebib Chekir; Yayoi Emi; Fujimi Arai; Yukako Kikuchi; Aiko Sasaki; Miwa Matsuda; Keiko Shimizu; Kazuhiro Tabuchi; Yasuhiko Kamada; Yuji Hiramatsu; Mikiya Nakatsuka
Journal:  J Obstet Gynaecol Res       Date:  2012-04-09       Impact factor: 1.730

2.  Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action.

Authors:  George A Mensah
Journal:  Circulation       Date:  2005-03-15       Impact factor: 29.690

3.  Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.

Authors:  Justine Defreyne; Laurens D L Van de Bruaene; Ernst Rietzschel; Judith Van Schuylenbergh; Guy G R T'Sjoen
Journal:  Clin Chem       Date:  2019-01       Impact factor: 8.327

4.  Surgical and pharmacological reassignment: influence on transsexual cardiovascular risk profile.

Authors:  Marco M Ciccone; Giuseppe Loverro; Pietro Scicchitano; Matteo Loverro; Gabriella Ricci; Francesca Scaramuzzi; Michele Gesualdo; Annapaola Zito; Marcello Campagna; Michele Moncelli; Vittorio Nicolardi; Fabio Manca; Barbara Boninfante; Santa Carbonara; Francesca Cortese; Orlando Todarello; Carlo Bettocchi
Journal:  Intern Med J       Date:  2017-11       Impact factor: 2.048

5.  Gender minority social stress in adolescence: disparities in adolescent bullying and substance use by gender identity.

Authors:  Sari L Reisner; Emily A Greytak; Jeffrey T Parsons; Michele L Ybarra
Journal:  J Sex Res       Date:  2014-04-17

6.  Meeting the Patient Care, Education, and Research Missions: Academic Medical Centers Must Comprehensively Address Sexual and Gender Minority Health.

Authors:  Carl G Streed; Mitchell R Lunn; Jennifer Siegel; Juno Obedin-Maliver
Journal:  Acad Med       Date:  2021-06-01       Impact factor: 6.893

7.  The Effects of Gender- and Sexuality-Based Harassment on Lesbian, Gay, Bisexual, and Transgender Substance Use Disparities.

Authors:  Robert W S Coulter; Melina Bersamin; Stephen T Russell; Christina Mair
Journal:  J Adolesc Health       Date:  2017-12-11       Impact factor: 5.012

8.  The Moderating Role of Coping Style on Chronic Stress Exposure and Cardiovascular Reactivity Among African American Emerging Adults.

Authors:  Lucia Cavanagh; Ezemenari M Obasi
Journal:  Prev Sci       Date:  2021-04

9.  Health and Cardiometabolic Disease in Transgender Adults in the United States: Behavioral Risk Factor Surveillance System 2015.

Authors:  Natalie J Nokoff; Sharon Scarbro; Elizabeth Juarez-Colunga; Kerrie L Moreau; Allison Kempe
Journal:  J Endocr Soc       Date:  2018-03-05

10.  Tobacco Use Among Transgender and Gender Non-conforming Adults in the United States.

Authors:  Christopher W Wheldon; Kara P Wiseman
Journal:  Tob Use Insights       Date:  2019-05-23
View more
  14 in total

1.  Examining the associations of gender minority stressors with sleep health in gender minority individuals.

Authors:  Billy A Caceres; Kasey B Jackman; Joseph Belloir; Jordan Dworkin; Curtis Dolezal; Dustin T Duncan; Walter O Bockting
Journal:  Sleep Health       Date:  2021-12-23

2.  Multicenter Analysis of Cardiometabolic-related Diagnoses in Transgender and Gender-Diverse Youth: A PEDSnet Study.

Authors:  Anna Valentine; Shanlee Davis; Anna Furniss; Nadia Dowshen; Anne E Kazak; Christopher Lewis; Danielle F Loeb; Leena Nahata; Laura Pyle; Lisa M Schilling; Gina M Sequeira; Natalie Nokoff
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 3.  HIV and cardiovascular disease: the role of inflammation.

Authors:  Sahera Dirajlal-Fargo; Nicholas Funderburg
Journal:  Curr Opin HIV AIDS       Date:  2022-07-05       Impact factor: 4.061

4.  Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus.

Authors:  Jordan E Lake; Ruibin Wang; Benjamin W Barrett; Emily Bowman; Ana N Hyatt; Paula Debroy; Jury Candelario; Linda Teplin; Kaitlin Bodnar; Heather McKay; Michael Plankey; Todd T Brown; Nicholas Funderburg; Judith S Currier
Journal:  AIDS       Date:  2022-08-10       Impact factor: 4.632

5.  Distribution of High-Sensitivity Cardiac Troponin and N-Terminal Pro-Brain Natriuretic Peptide in Healthy Transgender People.

Authors:  Dina N Greene; Robert L Schmidt; Robert H Christenson; Jessica Rongitsch; Katherine L Imborek; Heather Rebuck; Thomas S Lorey; Amy K Saenger; Matthew D Krasowski
Journal:  JAMA Cardiol       Date:  2022-10-05       Impact factor: 30.154

6.  Challenges and inclusive practices for LGBTQIA2S+ scientists in the American Physiological Society.

Authors:  Jesse D Moreira; Melissa L Bates; Troy A Roepke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-10       Impact factor: 5.125

Review 7.  Health Communication and Sexual Orientation, Gender Identity, and Expression.

Authors:  Carl G Streed
Journal:  Med Clin North Am       Date:  2022-05-28       Impact factor: 6.912

8.  Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy.

Authors:  Aaren Kettelhut; Emily Bowman; Janelle Gabriel; Brittany Hand; Namal P M Liyanage; Manjusha Kulkarni; Frances Avila-Soto; Jordan E Lake; Nicholas T Funderburg
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

9.  Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons.

Authors:  Vin Tangpricha
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

Review 10.  Diet, Food Insecurity, and CVD Risk in Sexual and Gender Minority Adults.

Authors:  Billy A Caceres; Melissa Bynon; Danny Doan; Nour Makarem; Amanda C McClain; Nicole VanKim
Journal:  Curr Atheroscler Rep       Date:  2022-02-02       Impact factor: 5.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.